Cardiff Lexington Corp (CDIX)

[KeepItRealistic]

Received Clarification on this small OS increase

Two Note’s on the 13th and future notes have been payed off

A legacy note which Is nearing its end, which company could not pay off is being absorbed

It’s not substantial and should be easily absorbed

So if you read the PR it’s 100% factual

Retail overreacting to the remaining controlled dilution today imo

$CDIX’s last PR could not have made it any clearer their intentions to acquire Acela by their actions taken

Cardiff Lexington Corporation  (CDIX) Shores Up Balance Sheet with Capital Infusion; Eliminates Convertible Debts

2019-09-11, 8:45 AM

FT. LAUDERDALE, Fla., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Cardiff Lexington (OTC: CDIX)  Cardiff Lexington, a public holding company, today announced that the Company has received $410,000.00 in new funding from the Private Equity Group, Leonite Capital, LLC. The parties entered into a 12-month conventional note. This capital infusion was arranged  by the registered Broker Dealer Craft Capital, LLC to stop the current convertible note dilution of Cardiff Lexington common stock and in an attempt to stabilize the share price of the Company.

Cardiff has paid-off three significant convertible notes totaling $379,902 and plans to retire all commercial notes by year end 2019 in concert with acquisition related equity funding. This move consolidates Company debt with essentially two friendly lenders Leonite Capital LLC and Greentree Financial, LLC both of whom have invested prior, are committed to future equity participations,  and are aligned and committed to Cardiff Lexington’s future goals and objectives.

Alex Cunningham, CEO/President of Cardiff Lexington, stated: “The elimination of troubling debt conversions from our balance sheet and move to an equity blend of financing should have a positive effect to help strengthen the value of our company and our common share market price. Paying off this currently converting convertible debt, will dramatically ease troubling dilution which has consistently put extreme pressure on our common stock price.  Our goal is to continue to reward our shareholders and new investors of Cardiff Lexington by organic growth through an increasing common stock price and expanding our revenue streams through new acquisitions including real estate and companies vertically and horizontally aligned with the CBD Oil Medical Hemp business. ”  “These moves combined with our  pending potential Acela BioMedical acquisition  in my opinion will immediately validate our higher standing within the small cap market segment as we continue to gain national attention of our business strategy as one of the more stable innovative fully reporting Companies in our industry,” further stated Cunningham.
About Cardiff Lexington Corporation: Cardiff Lexington is a public holding company, much like a cooperative, leveraging proven management in private companies that   become subsidiaries. Our focus is not industry or geographic-specific, but rather proven management, market, and margin. Cardiff Lexington targets acquisitions of mature, high growth, niche companies. Cardiff Lexington's strategy identifies and empowers select income-producing middle market private businesses and commercial real estate properties. Cardiff Lexington provides these companies both 1) the enhanced ability to raise money for operations or expansion, and 2) an equity exit and liquidity strategy for the owner, heirs, and/or Investors. For investors, Cardiff Lexington provides a diversified lower risk to protect and safely enhance their investment by  continually adding assets and holdings. Cardiff Lexington is led by strong and talented team of executives and advisors providing expert acquisition, market guidance and added value for subsidiaries and  investors.

FORWARD LOOKING STATEMENT: This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements  reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance   requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.
Investors Relations 800-628- 2100  ext. 705
[e-mail]


$CDIX Monthly stats & DD

CDIX’s average volume for the last month was 111 million per trading day
https://ih.advfn.com/stock-market/USOTC/cardiff-lexington-corporation-CDIX/historical

Also another stats of interest is the average pps over the last month called VWAP

VWAP is .0055 over past month

20 trading days in a month

So 20 times 111m is 2200 million shares traded at .0055 avg

That’s a staggering $12.1 million dollars of trading volume in the last month on a 382m float

This type of $$$ interest happens for a reason

Float has remained unchanged for last 4 daily updates ever since company announced the settlement of there toxic debt

$CDIX float remains at 382 million after 4 consecutive daily OTC updates, since company said 2019 notes were payed offhttps://t.co/iOPFxpI0Gy

PPS has nowhere to go but up with pending acquisition catalyst and with the absence of conversions to slow it down this time around pic.twitter.com/MVW4nwINac

— KIR (@KeepRealistic) September 14, 2019

Looking at the big picture we can see that they paid off the current debt that was preventing them to finalize the Acela Acquisition which would be the only obvious incentive.

The two notes due September 13th are included and when in doubt daily OS updates will reassure you.

Now, Once the deal is closed the pps will be much much higher which in turn means alot less shares hitting the market to service any future debt.

CDIX investors: 5 DD Links ~ MUST READ~

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151146856

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151083024

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150916701

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151166240

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150719782